Overcome hurdles in scaling up mRNA-based therapeutics
Explore ways to resolve three of the key challenges in the field of mRNA-based therapies
Stay updated with breaking news from Rna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Explore ways to resolve three of the key challenges in the field of mRNA-based therapies
In a pioneering move, researchers at The Florey Institute have developed a novel method utilizing mRNA technology to directly target the tau protein, which plays a critical role in the development of Alzheimer's disease and other dementia-related conditions. This innovative approach marks the first time mRNA, widely recognized for its role in COVID-19 vaccines, has been applied to Alzheimer's disease, positioning The Florey as a leader in mRNA research.
Molecure S.A., a leading biotechnology company focused on drug discovery and development, has unveiled its annual report for 2023 at the start of the new financial year.
"Discover the latest trends in compensation for anesthesia providers, as CRNAs see higher pay increases compared to anesthesiologists, according to a report fro
More than a few of these models never reached our shores, and from the looks of things, it was probably best that they didn't.